Oric Pharmaceuticalsinc Stock Price Prediction

ORIC Stock  USD 9.51  0.25  2.56%   
At the present time, the RSI of Oric PharmaceuticalsI's share price is approaching 32. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Oric PharmaceuticalsI, making its price go up or down.

Oversold Vs Overbought

32

 
Oversold
 
Overbought
Oric PharmaceuticalsInc stock price prediction is an act of determining the future value of Oric PharmaceuticalsI shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Oric PharmaceuticalsI's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Oric PharmaceuticalsI and does not consider all of the tangible or intangible factors available from Oric PharmaceuticalsI's fundamental data. We analyze noise-free headlines and recent hype associated with Oric PharmaceuticalsInc, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Oric PharmaceuticalsI's stock price prediction:
EPS Estimate Next Quarter
(0.51)
EPS Estimate Current Year
(1.75)
EPS Estimate Next Year
(1.95)
Wall Street Target Price
19.14
EPS Estimate Current Quarter
(0.49)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Oric PharmaceuticalsI based on different types of headlines from major news networks to social media. The Oric stock price prediction module provides an analysis of price elasticity to changes in media outlook on Oric PharmaceuticalsI over a specific investment horizon. Using Oric PharmaceuticalsI hype-based prediction, you can estimate the value of Oric PharmaceuticalsInc from the perspective of Oric PharmaceuticalsI response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Oric PharmaceuticalsI using Oric PharmaceuticalsI's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Oric using crowd psychology based on the activity and movement of Oric PharmaceuticalsI's stock price.

Oric PharmaceuticalsI Implied Volatility

    
  507.09  
Oric PharmaceuticalsI's implied volatility exposes the market's sentiment of Oric PharmaceuticalsInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Oric PharmaceuticalsI's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Oric PharmaceuticalsI stock will not fluctuate a lot when Oric PharmaceuticalsI's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Oric PharmaceuticalsI. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Oric PharmaceuticalsI to buy its stock at a price that has no basis in reality. In that case, they are not buying Oric because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Oric PharmaceuticalsI after-hype prediction price

    
  USD 9.5  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Oric PharmaceuticalsI Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oric PharmaceuticalsI's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
6.3811.0615.74
Details
Naive
Forecast
LowNextHigh
6.2510.9315.61
Details
9 Analysts
Consensus
LowTargetHigh
14.4315.8617.60
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.46-0.42-0.39
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Oric PharmaceuticalsI. Your research has to be compared to or analyzed against Oric PharmaceuticalsI's peers to derive any actionable benefits. When done correctly, Oric PharmaceuticalsI's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Oric PharmaceuticalsInc.

Oric PharmaceuticalsI After-Hype Price Prediction Density Analysis

As far as predicting the price of Oric PharmaceuticalsI at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oric PharmaceuticalsI or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Oric PharmaceuticalsI, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Oric PharmaceuticalsI Estimiated After-Hype Price Volatility

In the context of predicting Oric PharmaceuticalsI's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oric PharmaceuticalsI's historical news coverage. Oric PharmaceuticalsI's after-hype downside and upside margins for the prediction period are 4.82 and 14.18, respectively. We have considered Oric PharmaceuticalsI's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
9.51
9.50
After-hype Price
14.18
Upside
Oric PharmaceuticalsI is somewhat reliable at this time. Analysis and calculation of next after-hype price of Oric PharmaceuticalsInc is based on 3 months time horizon.

Oric PharmaceuticalsI Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Oric PharmaceuticalsI is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oric PharmaceuticalsI backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oric PharmaceuticalsI, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.02 
4.68
  0.01 
 0.00  
11 Events / Month
2 Events / Month
In about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
9.51
9.50
0.11 
1,510  
Notes

Oric PharmaceuticalsI Hype Timeline

Oric PharmaceuticalsInc is now traded for 9.51. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. Oric is forecasted to decline in value after the next headline, with the price expected to drop to 9.5. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.11%, whereas the daily expected return is now at 0.02%. The volatility of related hype on Oric PharmaceuticalsI is about 6423.53%, with the expected price after the next announcement by competition of 9.51. About 88.0% of the company shares are owned by institutional investors. The book value of Oric PharmaceuticalsI was now reported as 4.08. The company recorded a loss per share of 1.96. Oric PharmaceuticalsInc had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days.
Check out Oric PharmaceuticalsI Basic Forecasting Models to cross-verify your projections.

Oric PharmaceuticalsI Related Hype Analysis

Having access to credible news sources related to Oric PharmaceuticalsI's direct competition is more important than ever and may enhance your ability to predict Oric PharmaceuticalsI's future price movements. Getting to know how Oric PharmaceuticalsI's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oric PharmaceuticalsI may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
HFBLHome Federal Bancorp 0.13 9 per month 0.00 (0.12) 3.92 (3.87) 11.57 
BWMXBetterware De Mexico(0.62)7 per month 1.99  0.20  5.55 (3.21) 16.47 
PVBCProvident Bancorp(0.02)6 per month 0.00 (0.24) 3.01 (3.22) 10.45 
HTLFPHeartland Financial USA 0.00 0 per month 0.84 (0.04) 1.45 (1.32) 5.37 
NRDBYNordea Bank Abp 0.00 0 per month 0.00 (0.10) 1.97 (2.27) 10.67 
CFXConflux Network 0.00 0 per month 7.80  0.05  13.64 (14.29) 46.05 
C-PNCitigroup Capital XIII 0.00 0 per month 0.48  0.02  0.51 (0.64) 5.08 

Oric PharmaceuticalsI Additional Predictive Modules

Most predictive techniques to examine Oric price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oric using various technical indicators. When you analyze Oric charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Oric PharmaceuticalsI Predictive Indicators

The successful prediction of Oric PharmaceuticalsI stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Oric PharmaceuticalsInc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Oric PharmaceuticalsI based on analysis of Oric PharmaceuticalsI hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Oric PharmaceuticalsI's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oric PharmaceuticalsI's related companies.
 2021 2022 2023 2024 (projected)
Current Ratio15.8713.6810.3919.54
Net Debt To EBITDA2.840.780.120.11

Story Coverage note for Oric PharmaceuticalsI

The number of cover stories for Oric PharmaceuticalsI depends on current market conditions and Oric PharmaceuticalsI's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oric PharmaceuticalsI is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oric PharmaceuticalsI's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Oric PharmaceuticalsI Short Properties

Oric PharmaceuticalsI's future price predictability will typically decrease when Oric PharmaceuticalsI's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oric PharmaceuticalsInc often depends not only on the future outlook of the potential Oric PharmaceuticalsI's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oric PharmaceuticalsI's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding51.5 M
Cash And Short Term Investments208.2 M
When determining whether Oric PharmaceuticalsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oric PharmaceuticalsI's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oric Pharmaceuticalsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oric Pharmaceuticalsinc Stock:
Check out Oric PharmaceuticalsI Basic Forecasting Models to cross-verify your projections.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Oric Stock analysis

When running Oric PharmaceuticalsI's price analysis, check to measure Oric PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric PharmaceuticalsI is operating at the current time. Most of Oric PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Oric PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Oric PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Oric PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric PharmaceuticalsI. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.96)
Return On Assets
(0.28)
Return On Equity
(0.45)
The market value of Oric PharmaceuticalsInc is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Oric PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Oric PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oric PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.